Latest news
Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 20:14:11 GMTContext Therapeutics Receives Nasdaq Minimum Bid Price Notice - The Globe and MailThe Globe and Mail · Sat, 01 Aug 2026 20:34:00 GMTCrude Oil Volatility in Context - The Globe and MailThe Globe and Mail · Tue, 28 Jul 2026 15:37:00 GMT